Researchers have investigated the diagnostic correctness of hs-cTnT for the diagnosis of non-ST elevation acute coronary syndrome (NSTE-ACS) needing revascularization in a sizable cohort of patients with severe CKD (eGFR <30 mL/min/1.73 m2), involving individuals with CKD G5D [3]. Here, TNNT2 is linked to chronic kidney disease.